Stocktoria
OPKO HEALTH, INC. OPK
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1995-11-02
OPKO HEALTH, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 33.9% | 30.6% | 36.8% | 28.7% | — |
| Operating margin | -19.3% | -21.3% | -18.2% | -22.5% | 1.1% |
| Net margin | -37.2% | -7.5% | -21.9% | -32.7% | -1.7% |
| Return on assets | -11.7% | -2.4% | -9.4% | -15.2% | -1.3% |
| Return on equity | -17.8% | -3.9% | -13.6% | -21.0% | -1.8% |
| Debt / equity | 0.27× | 0.32× | 0.01× | 0.16× | 0.12× |
| Current ratio | 3.97 | 3.43 | 1.55 | 1.85 | 2.49 |
| Revenue growth | -14.9% | -17.4% | -14.0% | -43.4% | 23.6% |
Source: SEC EDGAR filings · CIK 0000944809 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.